[Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
In a randomized double-blind study i.v. PGE1 (60 mcg) leads to a significant increase of femoral blood flow, of tcPO2 and skin temperature. This effect lasts for more than one hour after infusion. Besides a slight decrease of blood pressure no severe side effects could be confirmed.